As its name suggests, this treatment is enriched with tranexamic acid, but it also contains antioxidant-rich aai extract and vitamin C to enhance its skin-brightening properties
Key findings from the 48-week study include: Significant Weight Loss: Subjects receiving pemvidutide achieved mean weight losses of 10.3%, 11.2%, and 15.6% at the 1.2 mg, 1.8 mg, and 2.4 mg doses, respectively, compared to 2.2% for placebo
Still, the factors responsible for an effective and long-lasting antibody response remains unclear
The prevailing understanding is that BPC 157s systemic action is sufficient, making SubQ injections effective, safer, and easier to administer for virtually all applications